Preliminary scientific tests indicate conolidine may possibly inhibit certain ion channels, reducing neuronal excitability and limiting pain signals. This system is particularly appropriate in neuropathic suffering, the place abnormal signaling results in persistent discomfort. On top of that, conolidine appears to affect G protein-coupled receptor